Cancer-associated venous thromboembolic disease, version 2.2024 Guidelines
| Authors: | Streiff, M. B.; Holmstrom, B.; Angelini, D.; Ashrani, A.; Buckner, T.; Diep, R.; Fertrin, K. Y.; Fogerty, A. E.; Crestani, N. G.; Gangaraju, R.; Rojas-Hernandez, C.; Goldhaber, S. Z.; Ibrahim, I.; Kubal, T.; Leavitt, A. D.; Lim, M.; Mann, J.; Mantha, S.; Morton, C.; Nester, A.; O’Brien, A.; Ortel, T. L.; Pine, A.; Pishko, A.; Ranade, M.; Salmasi, A.; Schaefer, J.; Williams, E.; Wool, G.; Wun, T.; Montgomery, S.; Nguyen, J.; Freedman-Cass, D.; Sliker, B. |
| Title: | Cancer-associated venous thromboembolic disease, version 2.2024 |
| Abstract: | The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease provide strategies for the prevention, diagnosis, and treatment of venous thromboembolism (VTE) in adult patients with cancer. VTE is a common and life-threatening condition in patients with cancer, and its management often requires multidisciplinary efforts. The NCCN panel is comprised of specialists spanning various fields, including cardiology, hematology, medical oncology, internal medicine, interventional radiology, and pharmacology. The content featured in this issue specifically addresses the evaluation and recommended treatment options outlined in the NCCN Guidelines for the diverse subtypes of cancer-associated VTE. © JNCCN—Journal of the National Comprehensive Cancer Network. |
| Keywords: | drug efficacy; follow up; neoplasm; neoplasms; disease association; anticoagulant therapy; deep vein thrombosis; practice guideline; oncology; risk factor; lung embolism; diagnosis; anticoagulants; warfarin; heparin; interventional radiology; medical oncology; medical specialist; disease management; portal vein thrombosis; therapy; pharmacology; fondaparinux; liver vein thrombosis; prevention and control; low molecular weight heparin; venous thromboembolism; anticoagulant agent; rivaroxaban; fibrinolytic therapy; hematology; mesenteric vein thrombosis; cardiology; etiology; thrombectomy; internal medicine; catheter thrombosis; complication; procedures; thrombosis prevention; activated partial thromboplastin time; humans; human; article; malignant neoplasm; splanchnic vein thrombosis; postthrombosis syndrome |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 22 |
| Issue: | 7 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2024-09-01 |
| Start Page: | 483 |
| End Page: | 506 |
| Language: | English |
| DOI: | 10.6004/jnccn.2024.0046 |
| PUBMED: | 39236759 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Source: Scopus |
